1595 related articles for article (PubMed ID: 7750465)
21. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats.
Nian H; Qin LP; Chen WS; Zhang QY; Zheng HC; Wang Y
Acta Pharmacol Sin; 2006 Jun; 27(6):728-34. PubMed ID: 16723092
[TBL] [Abstract][Full Text] [Related]
23. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
24. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
Kangas L; Härkönen P; Väänänen K; Peng Z
Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
[TBL] [Abstract][Full Text] [Related]
25. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
26. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
27. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
[TBL] [Abstract][Full Text] [Related]
29. Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice.
Wu J; Wang XX; Takasaki M; Ohta A; Higuchi M; Ishimi Y
J Bone Miner Res; 2001 Oct; 16(10):1829-36. PubMed ID: 11585347
[TBL] [Abstract][Full Text] [Related]
30. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Evans G; Bryant HU; Magee D; Sato M; Turner RT
Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
[TBL] [Abstract][Full Text] [Related]
31. The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia.
Stancíková M; Svík K; Istok R; Rovenský J; Velebný V
Int J Tissue React; 2004; 26(1-2):9-16. PubMed ID: 15573687
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
Ke HZ; Li M; Jee WS
Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
[TBL] [Abstract][Full Text] [Related]
33. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
34. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of bone architecture and biomechanic properties by peripheral quantitative computed tomography in rats].
Xing XP; Xia WB; Meng XW; Zhou XY; Hu YY; Liu HC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):791-5. PubMed ID: 12899761
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
38. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
Osterman T; Laurén L; Kuurtamo P; Hannuniemi R; Isaksson P; Kippo K; Peng Z; Väänänen HK; Sellman R
J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
[TBL] [Abstract][Full Text] [Related]
39. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
[TBL] [Abstract][Full Text] [Related]
40. The effect of olpadronate in ovariectomized thyroxine-treated rats.
Zeni S; Gomez-Acotto C; Mautalen C
Bone; 1997 Oct; 21(4):329-33. PubMed ID: 9315336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
